Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015.
Farkas S, Nagy K, Jia Z, Harkany T, Palkovits M, Donohou SR, Pike VW, Halldin C, Máthé D, Csiba L, Gulyás B. Farkas S, et al. Among authors: gulyas b. Brain Res Bull. 2012 Apr 10;87(6):504-10. doi: 10.1016/j.brainresbull.2012.02.012. Epub 2012 Mar 7. Brain Res Bull. 2012. PMID: 22421165 Free PMC article.
Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.
Farkas S, Nagy K, Jia Z, Hortobágyi T, Varrone A, Halldin C, Csiba L, Gulyás B. Farkas S, et al. Among authors: gulyas b. Brain Res. 2012 May 9;1453:56-63. doi: 10.1016/j.brainres.2012.03.014. Epub 2012 Mar 14. Brain Res. 2012. PMID: 22480734
In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse.
Máthé D, Horváth I, Szigeti K, Donohue SR, Pike VW, Jia Z, Ledent C, Palkovits M, Freund TF, Halldin C, Gulyás B. Máthé D, et al. Among authors: gulyas b. Brain Res Bull. 2013 Feb;91:46-51. doi: 10.1016/j.brainresbull.2013.01.001. Epub 2013 Jan 11. Brain Res Bull. 2013. PMID: 23318272 Free PMC article.
A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system.
Gulyás B, Makkai B, Kása P, Gulya K, Bakota L, Várszegi S, Beliczai Z, Andersson J, Csiba L, Thiele A, Dyrks T, Suhara T, Suzuki K, Higuchi M, Halldin C. Gulyás B, et al. Neurochem Int. 2009 Jan;54(1):28-36. doi: 10.1016/j.neuint.2008.10.001. Epub 2008 Oct 15. Neurochem Int. 2009. PMID: 18984021
Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patients.
Gulyás B, Spenger C, Beliczai Z, Gulya K, Kása P, Jahan M, Jia Z, Weber U, Pfeifer A, Muhs A, Willbold D, Halldin C. Gulyás B, et al. Neurochem Int. 2012 Jan;60(2):153-62. doi: 10.1016/j.neuint.2011.10.010. Epub 2011 Nov 12. Neurochem Int. 2012. PMID: 22100791
The norepinephrine transporter (NET) radioligand (S,S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study.
Gulyás B, Brockschnieder D, Nag S, Pavlova E, Kása P, Beliczai Z, Légrádi A, Gulya K, Thiele A, Dyrks T, Halldin C. Gulyás B, et al. Neurochem Int. 2010 May-Jun;56(6-7):789-98. doi: 10.1016/j.neuint.2010.03.001. Epub 2010 Mar 6. Neurochem Int. 2010. PMID: 20211213 Free article.
297 results